FOLH1 and bone metastasis: Although strong data exists with regards to sensitivity and specificity in the detection of either lymph nodes and bone metastasis with various Gallium and Fluoride-labelled PSMA tracers, randomized controlled trials aimed to evaluate the real impact of the result of PSMA PET/CT the subsequent treatment choice and the related patient outcome are lacking.